Fig. 7.
Fig. 7. (A) Percentage of MKs classified on the basis of nuclear lobes as evaluated by optical microscopy: cells were treated with 20 or 200 ng/mL of recombinant Tat protein starting from day 0 and harvested at day 12 (results from a representative experiment). (□) Tat 20 ng; (▪) Tat 200 ng; (▨) control. (B) Flow cytometry analysis of CD61, CD62, and CD41b expression in day 9 MKs grown in either absence (control) or presence of Tat protein (20 or 200 ng/mL starting from day 0 of culture). The negative control is shown on the far left in each panel (thin line peak).

(A) Percentage of MKs classified on the basis of nuclear lobes as evaluated by optical microscopy: cells were treated with 20 or 200 ng/mL of recombinant Tat protein starting from day 0 and harvested at day 12 (results from a representative experiment). (□) Tat 20 ng; (▪) Tat 200 ng; (▨) control. (B) Flow cytometry analysis of CD61, CD62, and CD41b expression in day 9 MKs grown in either absence (control) or presence of Tat protein (20 or 200 ng/mL starting from day 0 of culture). The negative control is shown on the far left in each panel (thin line peak).

Close Modal

or Create an Account

Close Modal
Close Modal